Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $41.18 million. The enterprise value is -$91.33 million.
Important Dates
The last earnings date was Wednesday, March 19, 2025, after market close.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.05 million shares outstanding. The number of shares has increased by 32.60% in one year.
Current Share Class | 86.05M |
Shares Outstanding | 86.05M |
Shares Change (YoY) | +32.60% |
Shares Change (QoQ) | +0.84% |
Owned by Insiders (%) | 4.46% |
Owned by Institutions (%) | 33.88% |
Float | 39.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.12 |
Forward PS | 0.93 |
PB Ratio | 0.27 |
P/TBV Ratio | 0.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.33.
Current Ratio | 1.50 |
Quick Ratio | 1.47 |
Debt / Equity | 0.33 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -73.14% and return on invested capital (ROIC) is -37.70%.
Return on Equity (ROE) | -73.14% |
Return on Assets (ROA) | -23.67% |
Return on Invested Capital (ROIC) | -37.70% |
Return on Capital Employed (ROCE) | -60.49% |
Revenue Per Employee | $43,927 |
Profits Per Employee | -$843,773 |
Employee Count | 150 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.79 million in taxes.
Income Tax | 1.79M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.99% in the last 52 weeks. The beta is 1.75, so IPSC's price volatility has been higher than the market average.
Beta (5Y) | 1.75 |
52-Week Price Change | -87.99% |
50-Day Moving Average | 0.71 |
200-Day Moving Average | 1.47 |
Relative Strength Index (RSI) | 30.08 |
Average Volume (20 Days) | 476,183 |
Short Selling Information
The latest short interest is 3.38 million, so 3.92% of the outstanding shares have been sold short.
Short Interest | 3.38M |
Short Previous Month | 3.41M |
Short % of Shares Out | 3.92% |
Short % of Float | 8.48% |
Short Ratio (days to cover) | 7.24 |
Income Statement
In the last 12 months, IPSC had revenue of $6.59 million and -$126.57 million in losses. Loss per share was -$1.61.
Revenue | 6.59M |
Gross Profit | -100.66M |
Operating Income | -135.17M |
Pretax Income | -131.64M |
Net Income | -126.57M |
EBITDA | -121.86M |
EBIT | -135.17M |
Loss Per Share | -$1.61 |
Full Income Statement Balance Sheet
The company has $189.29 million in cash and $53.83 million in debt, giving a net cash position of $135.46 million or $1.57 per share.
Cash & Cash Equivalents | 189.29M |
Total Debt | 53.83M |
Net Cash | 135.46M |
Net Cash Per Share | $1.57 |
Equity (Book Value) | 161.36M |
Book Value Per Share | 1.88 |
Working Capital | 64.27M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$110.14 million and capital expenditures -$154,000, giving a free cash flow of -$110.29 million.
Operating Cash Flow | -110.14M |
Capital Expenditures | -154,000 |
Free Cash Flow | -110.29M |
FCF Per Share | -$1.28 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -2,051.39% |
Pretax Margin | -1,893.70% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -32.60% |
Shareholder Yield | -32.60% |
Earnings Yield | -286.79% |
FCF Yield | -249.90% |
Analyst Forecast
The average price target for IPSC is $4.67, which is 875.76% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.67 |
Price Target Difference | 875.76% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | -41.63% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -3.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.52 |
Piotroski F-Score | 3 |